Skip to main content
. 2022 Jan 10;13:107. doi: 10.1038/s41467-021-27732-4

Fig. 3. GRH-1 dependency of nematodal lifespan-extension elicited by selected GRHL1-activating compounds.

Fig. 3

a Overview of impact of the respective compound (cpd) on lifespan of wild-type (WT) N2 nematodes at 1 µM in plate, as percentage change of mean lifespan vs. control treatment with DMSO (ctrl). Also see Fig. 2c–q. b Activation of GRHL reporter by the top 3 lifespan-extending compounds from (a) (Vstat = vorinostat, Papav = papaverine, Piperl = piperlongumine) at 5–10 µM in the presence (wild-type reporter with n = 4) or absence (two independent deletion reporters with n = 8 combined) of GRHL1. c, d Lifespan assays of vorinostat at 0.1 (c) or 10 µM (d) in plate, using WT (N2) nematodes and vs. DMSO control. e Lifespan assay of vorinostat at 10 µM in plate, using Δgrh-1 and vs. DMSO control. f, g Similar to (c), (d), using papaverine. h Similar to (e), using papaverine at 10 µM in plate. i, j Similar to (c), (d), using piperlongumine. k Similar to (e), using piperlongumine at 0.1 µM in plate. Data in bar graphs are mean ± SEM, with sample sizes as stated and individual data points representing biological replicates. P-values were determined with two-tailed unequal variances t-tests of the indicated comparisons of unpaired control vs. treatment groups. Lifespan graphs contain percentage change of mean lifespan compound vs. DMSO control and P-values as determined by log-rank test. See Supplementary Data 1 for detailed lifespan assay statistics. Source data are provided as a Source data file.